[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
PeptiDream Inc.
PeptiDream Inc. announces a milestone achievement in its collaboration with Asahi Kasei Pharma, with a peptide drug candidate selected for inflammatory diseases. Additionally, a Phase X clinical research for a novel gastric cancer targeting agent has been approved.
About PeptiDream Inc.
PeptiDream Inc. is a Japanese biotechnology company focused on therapeutic and diagnostic peptides.
Insights
- PeptiDream Inc. engagements is up XXXXX% from the previous week.
Price: $
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by positive news regarding product announcements, partnerships, and financial updates, as indicated by high social media engagement. However, the undefined market cap warrants caution.
1-Year High: $XXXXX on 2024-12-30
1-Year Low: $XXXXXXXX on 2025-12-03
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
PeptiDream Inc. is currently AltRank #1,000 based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2025-01-09
1-Year Low: XXX on 2025-03-31
Galaxy Score: XX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-02-18
1-Year Low: XX on 2025-01-01
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX +91%
X Month: XXXXX +8.60%
X Months: XXXXXX -XX%
X Year: XXXXXX +31%
1-Year High: XXXXXX on 2025-05-01
1-Year Low: X on 2025-01-03
Engagements by network (24h): Reddit: XX X: XX YouTube: XX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: X
X Week: XX +3%
X Month: XX +2.40%
X Months: XXX +58%
X Year: XXX +81%
1-Year High: XX on 2025-06-17
1-Year Low: X on 2024-12-15
Mentions by network (24h): Reddit: X X: XX YouTube: X
Creators: X (24h)
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning PeptiDream Inc. in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
X Week: XX -XX%
X Month: XX +13%
X Months: XX +25%
X Year: XXX +84%
1-Year High: XX on 2025-06-17
1-Year Low: X on 2024-12-15
The most influential creators that mention PeptiDream Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @PeptidreamInc | X | XX | X | XX |
| @GermanBiotech | X | XXXXX | X | XX |
| @MasatoMurakami5 | X | XX | X | XX |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% no change
X Year: XXX% +60%
1-Year High: XXX% on 2025-01-16
1-Year Low: XX% on 2025-02-26
Most Supportive Themes:
- Product Announcements and Presentations: (45%) Announcements regarding presentations at conferences like EANM2025 and JCA2025, showcasing peptide-based theranostic programs.
- Financial Updates and Partnerships: (30%) Positive news regarding capital investments, earnings reports, and partnerships with pharmaceutical companies.
- Sustainability and ESG Initiatives: (10%) Promotion of the company's commitment to sustainability and ESG through the release of the Sustainability Impact Report 2025.
Most Critical Themes:
- Market Cap Uncertainty: (15%) The market cap is undefined, which introduces uncertainty.
Market Cap: $undefined
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2024-12-30
1-Year Low: $XXXXXXXXXXXXXXX on 2025-02-12
Top PeptiDream Inc. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"China published 2025 NRDL adding XXX new drugs. Fosun Pharma inked outlicensing deal with Pfizer for obesity drug candidate. PeptiDream achieved milestone from collaboration program with Asahi Kasei"
X Link @Generic_Tina 2025-12-14T00:35Z XX followers, X engagements
"We are pleased to announce the approval of a Phase X clinical research for 64Cu-PD-29875 (targeting Claudin 18.2) in gastric cancer patients at the National Cancer Center Japan. jRCT Link: #Radiopharmaceuticals #Radioligandtherapy"
X Link @PeptidreamInc 2025-12-11T07:22Z XX followers, XX engagements
"We are excited to announce the nomination of a clinical development candidate from our collaboration with Asahi Kasei Pharma We look forward to further progress in the program and the advancement of the candidate into clinical development"
X Link @PeptidreamInc 2025-12-10T07:32Z XX followers, XX engagements
"📢 PeptiDream has achieved a milestone in its collaboration with Asahi Kasei Pharma following the selection of a peptide drug candidate for inflammatory diseases a major outcome of years of joint work using PDPS. 🔗 Press Release"
X Link @MasatoMurakami5 2025-12-09T23:55Z XX followers, XXX engagements